Macacine alphaherpesvirus 1: Difference between revisions
From IDWiki
m (Aidan moved page Herpes B virus to Macacine alphaherpesvirus 1) |
(→) |
||
Line 20: | Line 20: | ||
** Local symptoms (itching, tingling, numbness, or pain) at the inoculation site, with or without vesicular rash and regional lymphadenopathy |
** Local symptoms (itching, tingling, numbness, or pain) at the inoculation site, with or without vesicular rash and regional lymphadenopathy |
||
** Peripheral or central nervous system symptoms, with meningismus, vomiting, confusion, cranial nerve palsies |
** Peripheral or central nervous system symptoms, with meningismus, vomiting, confusion, cranial nerve palsies |
||
+ | * Eventually progresses to global encephalitis, seizures, paralysis, and respiratory failure |
||
+ | * Mortality 70% if untreated |
||
== Diagnosis == |
== Diagnosis == |
Revision as of 09:06, 15 October 2019
Background
- Also known as macacine herpesvirus 1, macacine alphaherpesvirus 1, cercopithecine herpesvirus 1, CHV-1), herpes B virus, monkey B virus, herpesvirus simiae and herpesvirus B
History
- First diagnosed in a researcher in 1933
Microbiology
- Double-stranded DNA virus
- Alphaherpesvirus, in the same family as HSV
Clinical Presentation
- Typically via bite or scratch of macaque monkey
- Asymptomatic or similar presentation to HSV in the monkey
- Seroprevalence reaches 100% in some populations of macaques
- Three clinical forms:
- Flu-like illness followed by CNS symptoms
- Local symptoms (itching, tingling, numbness, or pain) at the inoculation site, with or without vesicular rash and regional lymphadenopathy
- Peripheral or central nervous system symptoms, with meningismus, vomiting, confusion, cranial nerve palsies
- Eventually progresses to global encephalitis, seizures, paralysis, and respiratory failure
- Mortality 70% if untreated
Diagnosis
Management
References
- ^ Joshua Fierer. Herpes B Virus Encephalomyelitis Presenting as Ophthalmic Zoster. Annals of Internal Medicine. 1973;79(2):225. doi:10.7326/0003-4819-79-2-225.